Neogen Corporation Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures
Neogen Corporation (NEOG) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures of 512.00 thousand shares for the 12-month period ending 2014-05-31, per its 10-K filed 2014-07-30.
Discontinued
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod · last filed 2014-07-30
- Neogen Corporation share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for the quarter ending 2014-05-31 was 0.00 shares, a 100.00% decline year-over-year.
- Neogen Corporation share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for the quarter ending 2013-08-31 was 319.00K shares.
- Neogen Corporation share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for the quarter ending 2013-05-31 was 153.00K shares, a 3.16% decline year-over-year.
- Neogen Corporation share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for the quarter ending 2013-02-28 was 0.00 shares, a 100.00% decline year-over-year.
- Neogen Corporation share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for fiscal 2014 was 512.00K shares, a 11.55% increase from fiscal 2013.
- Neogen Corporation share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for fiscal 2013 was 459.00K shares, a 3.16% decline from fiscal 2012.
- Neogen Corporation share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for fiscal 2012 was 474.00K shares, a 61.77% increase from fiscal 2011.
- Neogen Corporation share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for fiscal 2011 was 293.00K shares, a 31.22% decline from fiscal 2010.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 12 month as first filed |
|---|---|---|---|---|---|
| 2014-05-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2014-07-30 | 512.00K shares 10-K · filed 2014-07-30 | |||
| 2014-02-28 | 512.00K shares 10-Q · filed 2014-04-04 | ||||
| 2013-11-30 | 512.00K shares 10-Q · filed 2014-01-09 | ||||
| 2013-08-31 | 319.00K shares 10-Q · filed 2013-09-30 | 472.00K shares derived: sum of 2 quarters · filed 2014-07-30 | 472.00K shares derived: sum of 3 quarters · filed 2014-07-30 | 778.00K shares derived: sum of 4 quarters · filed 2014-07-30 | |
| 2013-05-31 | 153.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2014-07-30 | 153.00K shares derived: sum of 2 quarters · filed 2014-07-30 | 459.00K shares derived: sum of 3 quarters · filed 2014-07-30 | 459.00K shares 10-K · filed 2014-07-30 | 306.00K shares 10-K · filed 2013-07-30 |
| 2013-02-28 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2013-03-28 | 306.00K shares derived: sum of 2 quarters · filed 2013-03-28 | 306.00K shares 10-Q · filed 2013-03-28 | 464.00K shares derived: sum of 4 quarters · filed 2014-07-30 | |
| 2012-11-30 | 306.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2012-12-28 | 306.00K shares 10-Q · filed 2012-12-28 | 464.00K shares derived: sum of 3 quarters · filed 2014-07-30 | 467.00K shares derived: sum of 4 quarters · filed 2014-07-30 | |
| 2012-08-31 | 0.00 shares 10-Q · filed 2012-09-28 | 158.00K shares derived: sum of 2 quarters · filed 2014-07-30 | 161.00K shares derived: sum of 3 quarters · filed 2014-07-30 | 474.00K shares derived: sum of 4 quarters · filed 2014-07-30 | |
| 2012-05-31 | 158.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2014-07-30 | 161.00K shares derived: sum of 2 quarters · filed 2014-07-30 | 474.00K shares derived: sum of 3 quarters · filed 2014-07-30 | 474.00K shares 10-K · filed 2014-07-30 | 316.00K shares 10-K · filed 2012-07-30 |
| 2012-02-29 | 3.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2012-03-30 | 316.00K shares derived: sum of 2 quarters · filed 2012-03-30 | 316.00K shares 10-Q · filed 2012-03-30 | ||
| 2011-11-30 | 313.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2011-12-30 | 313.00K shares 10-Q · filed 2011-12-30 | |||
| 2011-08-31 | 0.00 shares 10-Q · filed 2011-09-30 | ||||
| 2011-05-31 | 293.00K shares 10-K · filed 2013-07-30 | ||||
| 2010-05-31 | 426.00K shares 10-K · filed 2012-07-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |